01:25:01 EDT Thu 01 Oct 2026
Enter Symbol
or Name
USA
CA



Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026

2026-09-30 16:05 ET - News Release

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026

PR Newswire

BOSTON, Sept. 30, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2027 financial results at 6:00 am ET on Thursday, November 5, 2026. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 5, 2026.

The call can be accessed via teleconference at: Q2 2027 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/kf8g7up6

A replay of the conference call and webcast will be available for one year beginning on November 5, 2026 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our Apheresis business features proprietary technologies designed to enhance safety, yield, donor satisfaction and operational efficiency for plasma and blood collectors around the world. Our MedSurg business offers Blood Management Technologies to help inform treatment decisions and optimize the management of blood products, and Interventional Technologies, including advanced vascular closure systems and sensor-guided technologies, designed to drive procedural effectiveness and elevate the patient experience. To learn more about Haemonetics, visit www.haemonetics.com.


   
          Investor Contacts:



   Olga Guyette, Vice President-Investor Relations & Treasury   David Trenk, Sr. Manager-Investor
                                                                  Relations



   (781) 356-9763                                             
 (203) 733-4987



   
          
            olga.guyette@haemonetics.com                                           david.trenk@haemonetics.com

---




   
          Media Contact:



   Josh Gitelson, Sr. Director-Global Communications



   (781) 356-9776



   
          
            josh.gitelson@haemonetics.com

---

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2027-results-november-5-2026-302894803.html

SOURCE Haemonetics Corporation

© 2026 Canjex Publishing Ltd. All rights reserved.